Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Overweight 1Obesity 1Insulin Resistance 1Hyperandrogenism 1

Interventions

Exercise 24Metformin 23Resistance Training 8Nutrition Assessment 8Methods 8Tirzepatide 7Diet Therapy 7Diet 7Counseling 7Early Intervention, Educational 6Caloric Restriction 6Exenatide 5semaglutide 4Liraglutide 4Educational Status 4Docosahexaenoic Acids 4Diet, Mediterranean 4Vitamin D 3Therapeutics 3Surveys and Questionnaires 3Sugars 3Standard of Care 3Dexamethasone 3Yoga 2Tablets 2Specimen Handling 2Progestins 2Ovidrel 2Nutritional Status 2Naltrexone 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Obesity × licogliflozin × Clear all
NCT03152591 2021-01-05

PCOS

Novartis

Phase 2 Completed
29 enrolled 24 charts
Other

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡